4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-25-000015
Chief Legal Officer & Corp Sec sold 11,122 shares at $1.84 ($20,506)
- Chief Legal Officer & Corp Sec acquired 66,800 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Derek M Chief Legal Officer & Corp Sec | 2025-01-03 | Sale 10b5-1 | −11,122 | $1.84 | $20,506 | 97,745 | D |
| Meisner Derek M Chief Legal Officer & Corp Sec | 2025-01-06 | Grant or award 10b5-1 | +66,800 | 164,545 | D | ||
| Derivatives | |||||||
| Meisner Derek M Chief Legal Officer & Corp Sec | 2025-01-06 | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +100,300 | 100,300 | D | ||
| Open-market sales · 11,122 sh · avg $1.84 · $20,506 | |||||||
Loading xslF345X05/wk-form4_1736297850.xml…